February 27, 2015 1:21 AM ET

Capital Markets

Company Overview of 5AM Venture Management LLC

Executive Profile

Kevin M. Forrest Ph.D.

Board Observer, Relypsa, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 7 different industries.

See Board Relationships
----

Background

Dr. Kevin M. Forrest, Ph.D., is a co-founder of Cidara Therapeutics, Inc. (K2 Therapeutics) and also serves as its Chief Operating Officer. He was a Principal at 5AM Venture Management LLC. Dr. Forrest served at this position since February 20, 2008. He joined 5AM Ventures in 2005 as a Senior Associate. . He also served as a Due Diligence Advisor at ProQuest Investments. Dr. Forrest serves on the board of VBI. He serves as a Board Observer of Ambrx, Relypsa, Biotech, ...

Corporate Headquarters

2200 Sand Hill Road
Menlo Park, California 94025

United States

Phone: 650-233-8600
Fax: 650-233-8923

Board Members Memberships

Board Observer
Board Observer
Former Director
Board Observer
Former Director
Former Director

Education

PhD
Princeton University
BS
Boston College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact 5AM Venture Management LLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.